American Portfolios Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$67.5K Sell
929
-205
-18% -$15.3K ﹤0.01% 1547
2022
Q2
$77.1K Buy
1,134
+10
+0.9% +$719 ﹤0.01% 1539
2022
Q1
$102K Buy
1,124
+31
+3% +$2.54K ﹤0.01% 1498
2021
Q4
$99.8K Buy
1,093
+953
+681% +$81.7K ﹤0.01% 1515
2021
Q3
$11.4K Buy
140
+115
+460% +$9.66K ﹤0.01% 2520
2021
Q2
$2.33K Hold
25
﹤0.01% 3116
2021
Q1
$2.67K Buy
+25
New +$2.59K ﹤0.01% 2906

Other funds holding NARI

American Portfolios Advisors's NARI Position: Q3 2022 in Review

American Portfolios Advisors reduced its Inari Medical, Inc. Common Stock (NARI) stake by 18% in Q3 2022, selling an estimated $15.3K and leaving 929 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

American Portfolios Advisors first reported a position in NARI in Q1 2021 and has held it in 7 quarters since. The position peaked at $102K in Q1 2022. 240 funds tracked by Wall St. Rank hold NARI as of Q3 2022.

  • American Portfolios Advisors held 929 shares of Inari Medical, Inc. Common Stock worth $67.5K as of Q3 2022.
  • American Portfolios Advisors sold 205 Inari Medical, Inc. Common Stock shares in Q3 2022, an estimated $15.3K.
  • Inari Medical, Inc. Common Stock made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1547 holding.
  • American Portfolios Advisors first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and has held it in 7 quarters since.
  • American Portfolios Advisors's Inari Medical, Inc. Common Stock position peaked at $102K in Q1 2022.
  • 240 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.